Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns

DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener. 2019;14:32. https://doi.org/10.1186/s13024-019-0333-5.

Article  PubMed  PubMed Central  Google Scholar 

Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R. Goedert, α-Synuclein in Lewy bodies. Nature. 1997;388:839–40. https://doi.org/10.1038/42166.

Article  CAS  PubMed  Google Scholar 

Hepp DH, Vergoossen DLE, Huisman E, Lemstra AW, Bank NB, Berendse HW, Rozemuller AJ, Foncke EMJ, Van De Berg WDJ. Distribution and load of amyloid-b pathology in Parkinson disease and dementia with lewy bodies. J Neuropathol Exp Neurol. 2016;75:936–45. https://doi.org/10.1093/jnen/nlw070.

Article  CAS  PubMed  Google Scholar 

Jellinger KA, Corey-Bloom J, Merdes AR, Hansen LA. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies [3] (multiple letters). Neurology. 2004;62:160. https://doi.org/10.1212/WNL.62.1.160.

Article  PubMed  Google Scholar 

Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia. Neurosci Lett. 2010;486:19–23. https://doi.org/10.1016/j.neulet.2010.09.036.

Article  CAS  PubMed  Google Scholar 

Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor J-P, Thomas A, Attems J, McKeith I. Dementia with Lewy bodies: an update and outlook. Mol Neurodegener. 2019;14:5. https://doi.org/10.1186/s13024-019-0306-8.

Article  PubMed  PubMed Central  Google Scholar 

Golde TE, Miller VM. Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer’s and other neurodegenerative diseases. Alzheimers Res Ther. 2009;1:5. https://doi.org/10.1186/alzrt5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hartl FU. Protein Misfolding Dis Annu Rev Biochem. 2017;86:21–6. https://doi.org/10.1146/annurev-biochem-061516-044518.

Article  CAS  Google Scholar 

Sami N, Rahman S, Kumar V, Zaidi S, Islam A, Ali S, Ahmad F, Hassan MI. Protein aggregation, misfolding and consequential human neurodegenerative diseases. Int J Neurosci. 2017;127:1047–57. https://doi.org/10.1080/00207454.2017.1286339.

Article  CAS  PubMed  Google Scholar 

Lutz HU, Binder CJ, Kaveri S. Naturally occurring auto-antibodies in homeostasis and disease. Trends Immunol. 2009;30:43–51. https://doi.org/10.1016/j.it.2008.10.002.

Article  CAS  PubMed  Google Scholar 

Wu J, Li L. Autoantibodies in Alzheimer’s disease: potential biomarkers, pathogenic roles, and therapeutic implications. J Biomed Res. 2016;30:361–72. https://doi.org/10.7555/JBR.30.20150131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciccocioppo F, Bologna G, Ercolino E, Pierdomenico L, Simeone P, Lanuti P, Pieragostino D, Del Boccio P, Marchisio M, Miscia S. Neurodegenerative diseases as proteinopathies-driven immune disorders. Neural Regen Res. 2020;15:850–6. https://doi.org/10.4103/1673-5374.268971.

Article  CAS  PubMed  Google Scholar 

Deleidi M, Maetzler W. Protein clearance mechanisms of alpha-synuclein and amyloid-Beta in lewy body disorders., Int. J. Alzheimers. Dis. 2012 (2012) 391438. https://doi.org/10.1155/2012/391438

Papuć E, Rejdak K. Anti-MAG autoantibodies are increased in Parkinson’s disease but not in atypical parkinsonism. J Neural Transm. 2017;124:209–16. https://doi.org/10.1007/s00702-016-1632-4.

Article  CAS  PubMed  Google Scholar 

Agrawal S, Abud EM, Snigdha S, Agrawal A. IgM response against amyloid-beta in aging: a potential peripheral protective mechanism. Alzheimers Res Ther. 2018;10:81. https://doi.org/10.1186/s13195-018-0412-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown EL, Essigmann HT, Hoffman KL, Alexander AS, Newmark M, Jiang Z-D, Suescun J, Schiess MC, Hanis CL, DuPont HL. IgA-Biome profiles correlate with clinical Parkinson’s Disease subtypes. J Parkinsons Dis. 2023;13:501–13. https://doi.org/10.3233/JPD-230066.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pocevičiūtė D, Nuñez-Diaz C, Roth B, Janelidze S, Giannisis A, Hansson O, Wennström M, Bank TNB. Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers. Alzheimers Res Ther. 2022;14:117. https://doi.org/10.1186/s13195-022-01062-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brudek T, Winge K, Folke J, Christensen S, Fog K, Pakkenberg B, Pedersen LØ. Autoimmune antibody decline in Parkinson’s disease and multiple system atrophy; a step towards immunotherapeutic strategies. Mol Neurodegener. 2017;12:44. https://doi.org/10.1186/s13024-017-0187-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Folke J, Rydbirk R, Løkkegaard A, Hejl A-M, Winge K, Starhof C, Salvesen L, Pedersen LØ, Aznar S, Pakkenberg B, Brudek T. Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson’s disease. Parkinsonism Relat Disord. 2021;87:98–104. https://doi.org/10.1016/j.parkreldis.2021.05.001.

Article  CAS  PubMed  Google Scholar 

Folke J, Bergholt E, Pakkenberg B, Aznar S, Brudek T. Alpha-synuclein autoimmune decline in Prodromal multiple system atrophy and Parkinson’s Disease. Int J Mol Sci. 2022;23:6554. https://doi.org/10.3390/ijms23126554.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jianping L, Zhibing Y, Wei Q, Zhikai C, Jie X, Jinbiao L. Low avidity and level of serum Anti-Aβ antibodies in Alzheimer Disease, Alzheimer dis. Assoc Disord 20 (2006). https://journals.lww.com/alzheimerjournal/Fulltext/2006/07000/Low_Avidity_and_Level_of_Serum_Anti_A__Antibodies.1.aspx

Folke J, Ferreira N, Brudek T, Borghammer P, Van Den Berge N. Passive Immunization in Alpha-Synuclein Preclinical Animal models. Biomolecules. 2022;12. https://doi.org/10.3390/biom12020168.

Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM. 2 investigators, Donanemab in early symptomatic Alzheimer Disease: the TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330:512–27. https://doi.org/10.1001/jama.2023.13239.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody. Alzheimers Res Ther. 2021;13:80. https://doi.org/10.1186/s13195-021-00813-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–601. https://doi.org/10.1002/mds.26424.

Article  PubMed  Google Scholar 

Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71:670–6. https://doi.org/10.1212/01.wnl.0000324625.00404.15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O’Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88–100. https://doi.org/10.1212/WNL.0000000000004058.

Article  PubMed  PubMed Central 

留言 (0)

沒有登入
gif